诊断皮肤病学影像设备市场—全球产业规模、份额、趋势、机会和预测（按模式、按应用、按最终用户、按地区和竞争细分，2020-2030 年）

2024 年全球诊断皮肤病影像设备市场价值为 51.3 亿美元，预计到 2030 年将达到 89.1 亿美元，复合年增长率为 9.62%。皮肤病患病率的不断上升以及对准确、早期和非侵入性诊断工具的需求推动了市场的成长。随着皮肤癌（尤其是黑色素瘤）对全球健康的威胁日益严重，对支持早期发现和有效管理的先进影像技术的需求也日益增加。患者对定期皮肤评估的认识不断提高，也促使医疗保健提供者采用创新的诊断设备。此外，人口老化和与生活方式相关的皮肤病（如痤疮、湿疹和牛皮癣）正在推动进一步的需求。影响市场的一个主要趋势是将人工智慧 (AI) 和机器学习整合到皮肤病学平台中，从而实现自动分析并提高诊断精度。行动、人工智慧和基于云端的成像系统的日益普及正在提高皮肤科实践的可及性、简化诊断并促进远端护理能力。

关键市场驱动因素

皮肤病和皮肤癌发生率上升

主要市场挑战

先进成像系统成本高昂

主要市场趋势

远距皮肤病学和远端诊断的发展

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球诊断皮肤病学影像设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按模式（先进诊断影像设备、表面视觉化设备、切片设备、分子诊断设备和平台）
  • 按应用（皮肤癌、发炎和自体免疫性皮肤病、感染性皮肤病、伤口和溃疡评估）
  • 按最终使用者（医院、皮肤科诊所/中心、癌症中心/肿瘤科诊所、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美诊断皮肤病学影像设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲诊断皮肤病学影像设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区诊断皮肤病学影像设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲诊断皮肤病学影像设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲诊断皮肤病学影像设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Canfield Scientific
• Caliber Imaging & Diagnostics
• Michelson Diagnostics (MDL)
• SciBase AB
• DermaSensor Inc.
• Damae Medical
• Apollo Medical Optics
• Enspectra Health, Inc.
• Dermavision Solutions
• Dermus Ltd.

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Diagnostic Dermatology Imaging Devices Market was valued at USD 5.13 Billion in 2024 and is projected to reach USD 8.91 Billion by 2030, registering a CAGR of 9.62%. Market growth is being propelled by the increasing prevalence of skin conditions and the need for accurate, early, and non-invasive diagnostic tools. With skin cancer, especially melanoma, posing a growing global health threat, there is heightened demand for advanced imaging technologies that support early detection and effective management. Rising patient awareness regarding regular skin evaluations is also prompting healthcare providers to adopt innovative diagnostic equipment. In addition, an aging population and lifestyle-related skin disorders such as acne, eczema, and psoriasis are driving further demand. A major trend shaping the market is the integration of artificial intelligence (AI) and machine learning into dermatology platforms, enabling automated analysis and enhanced diagnostic precision. The growing popularity of mobile, AI-enabled, and cloud-based imaging systems is improving accessibility, streamlining diagnosis, and fostering remote care capabilities in dermatology practices.

Key Market Drivers

Rising Incidence of Skin Disorders and Skin Cancer

The growing global incidence of skin disorders and skin cancer is a major driver for the increased use of diagnostic dermatology imaging devices. In the United States alone, skin cancer remains the most commonly diagnosed cancer, with an estimated 5.4 million cases reported annually. CDC data further highlights that more than 6.1 million adults are treated each year for basal and squamous cell carcinomas, incurring nearly USD 8.9 billion in treatment costs. Melanoma, while less prevalent, is notably aggressive, with approximately 200,340 cases projected in 2024, including 99,700 in situ and 100,640 invasive cases. Traditional assessment methods-such as manual examination-lack the depth and precision required for early detection. Devices like dermatoscopes, reflectance confocal microscopes, and optical coherence tomography provide non-invasive, real-time, cellular-level imaging, enhancing diagnostic accuracy and enabling earlier intervention. This contributes to significantly improved survival outcomes, as early-stage melanoma carries a five-year relative survival rate exceeding 94%.

Key Market Challenges

High Cost of Advanced Imaging Systems

The elevated cost of advanced imaging systems presents a significant obstacle to the broader adoption of diagnostic dermatology devices. Technologies such as high-resolution digital dermatoscopes, reflectance confocal microscopes, and optical coherence tomography scanners involve substantial initial investment. Smaller healthcare providers and facilities in under-resourced areas often struggle with the financial burden of procuring, maintaining, and upgrading this equipment. Additionally, ongoing expenses related to software updates, technical servicing, and clinician training further strain budgets. These financial limitations restrict the availability of advanced diagnostic tools in rural or low-income regions, thereby impeding timely diagnosis and treatment for underserved populations.

Key Market Trends

Growth of Teledermatology and Remote Diagnostics

A key trend reshaping the Global Diagnostic Dermatology Imaging Devices Market is the growing emphasis on teledermatology and remote diagnostic capabilities. The need for accessible skin healthcare in rural and underserved areas has spurred the development of compact, cloud-enabled imaging tools that facilitate real-time skin assessments and virtual consultations. These platforms allow patients to securely send high-resolution images of skin lesions to dermatologists, enabling remote analysis and timely diagnosis. This model improves convenience for patients and enhances dermatologists' efficiency by streamlining triage and reducing the need for in-person visits. Rising smartphone use and broader internet access further support the adoption of mobile imaging technologies, making them valuable instruments in expanding early diagnostic coverage.

Report Scope:

In this report, the Global Diagnostic Dermatology Imaging Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diagnostic Dermatology Imaging Devices Market, By Modality:

• Advanced Diagnostic Imaging Devices
• Surface Visualization Devices
• Biopsy Devices
• Molecular Diagnostic Devices & Platforms

Diagnostic Dermatology Imaging Devices Market, By Application:

• Skin Cancer
• Inflammatory & Autoimmune Skin Diseases
• Infectious Skin Conditions
• Wound & Ulcer Assessment

Diagnostic Dermatology Imaging Devices Market, By End User:

• Hospitals
• Dermatology Clinics/Centers
• Cancer Centers/Oncology Clinics
• Others

Diagnostic Dermatology Imaging Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Dermatology Imaging Devices Market.

Available Customizations:

Global Diagnostic Dermatology Imaging Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Diagnostic Dermatology Imaging Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Modality (Advanced Diagnostic Imaging Devices, Surface Visualization Devices, Biopsy Devices, Molecular Diagnostic Devices & Platforms)
  • 5.2.2. By Application (Skin Cancer, Inflammatory & Autoimmune Skin Diseases, Infectious Skin Conditions, Wound & Ulcer Assessment)
  • 5.2.3. By End User (Hospitals, Dermatology Clinics/Centers, Cancer Centers/Oncology Clinics, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Diagnostic Dermatology Imaging Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Modality
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Diagnostic Dermatology Imaging Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Modality
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Diagnostic Dermatology Imaging Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Modality
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Diagnostic Dermatology Imaging Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Modality
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Diagnostic Dermatology Imaging Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Modality
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Diagnostic Dermatology Imaging Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Modality
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Diagnostic Dermatology Imaging Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Modality
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Diagnostic Dermatology Imaging Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Modality
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Diagnostic Dermatology Imaging Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Modality
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Diagnostic Dermatology Imaging Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Modality
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Diagnostic Dermatology Imaging Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Modality
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Diagnostic Dermatology Imaging Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Modality
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Diagnostic Dermatology Imaging Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Modality
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Diagnostic Dermatology Imaging Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Modality
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Diagnostic Dermatology Imaging Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Modality
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Diagnostic Dermatology Imaging Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Modality
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Diagnostic Dermatology Imaging Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Modality
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Diagnostic Dermatology Imaging Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Modality
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Diagnostic Dermatology Imaging Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Modality
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Diagnostic Dermatology Imaging Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Modality
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Diagnostic Dermatology Imaging Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Modality
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Diagnostic Dermatology Imaging Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Modality
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Diagnostic Dermatology Imaging Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Modality
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Diagnostic Dermatology Imaging Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Modality
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Canfield Scientific
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Caliber Imaging & Diagnostics
• 15.3. Michelson Diagnostics (MDL)
• 15.4. SciBase AB
• 15.5. DermaSensor Inc.
• 15.6. Damae Medical
• 15.7. Apollo Medical Optics
• 15.8. Enspectra Health, Inc.
• 15.9. Dermavision Solutions
• 15.10. Dermus Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer